Tuesday, October 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1 Drug Recalled Nationwide Due To Possible Health Risks

A compounding pharmacy has recalled a GLP-1 drug that was distributed nationwide, according to

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 21 00:58 ETSource: Patch

From the source

GLP-1 Drug Recalled Nationwide Due To Possible Health Risks

A compounding pharmacy has recalled a GLP-1 drug that was distributed nationwide, according to authorities.

Read at patch.com
PeptiPrescribed peptides from $99/moSee all →